Sensitivity of new radiopharmaceuticals

被引：45
作者：
Eckelman, WC [1 ]
机构：
[1] NIH, Ctr Clin, PET Dept, Bethesda, MD 20892 USA
来源：
NUCLEAR MEDICINE AND BIOLOGY | 1998年 / 25卷 / 03期
关键词：
radiopharmaceutical development; sensitivity; PET; SPECT;
D O I：
10.1016/S0969-8051(97)00207-2
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：169 / 173
页数：5
相关论文
共 52 条
[1]   Development of central 5-HT2A receptor radioligands for PET: Comparison of [H-3]RP 62203 and [H-3]SR 46349B kinetics in rat brain [J].
Ashworth, S ;
Hume, SP ;
Lammertsma, AA ;
OpackaJuffry, J ;
Shah, F ;
Pike, VW .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (03) :245-250
[2]  
BERRIDGE MS, 1994, J NUCL MED, V35, P1665
[3]   In vivo binding of [F-18]altanserin to rat brain 5HT(2) receptors: A film and electronic autoradiographic study [J].
Biver, F ;
Lotstra, F ;
Monclus, M ;
Dethy, S ;
Damhaut, P ;
Wikler, D ;
Luxen, A ;
Goldman, S .
NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (04) :357-360
[4]  
BOGDANOVIC N, 1993, EXP BRAIN RES, V97, P225
[5]  
CARLSON R, 1993, J CEREB BLOOD FLOW M, V13, P24
[6]  
Carson Richard E., 1996, P167
[7]   IDENTIFIABILITY ANALYSIS AND PARAMETER-IDENTIFICATION OF AN INVIVO LIGAND-RECEPTOR MODEL FROM PET DATA [J].
DELFORGE, J ;
SYROTA, A ;
MAZOYER, BM .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1990, 37 (07) :653-661
[8]  
DICHINO D, 1983, J NUCL MED, V24, P1030
[9]  
DICHIRO C, 1991, J NUCL MED, V32, P1346
[10]   GLUCOSE-UTILIZATION OF CEREBRAL GLIOMAS MEASURED BY [F-18] FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
DICHIRO, G ;
DELAPAZ, RL ;
BROOKS, RA ;
SOKOLOFF, L ;
KORNBLITH, PL ;
SMITH, BH ;
PATRONAS, NJ ;
KUFTA, CV ;
KESSLER, RM ;
JOHNSTON, GS ;
MANNING, RG ;
WOLF, AP .
NEUROLOGY, 1982, 32 (12) :1323-1329
123456